REQUEST A DEMO
Total
USD $0.00
Search more companies

Acton Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Acton Pharma Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Acton Pharma Private Limited is an unlisted company, incorporated on 15/05/2012. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24232DL2012PTC235869 and registration number is 235869. The company is a trade company, it is engaged in wholesale trading.

Legal Address
49A, Navyug Appartments Ground Floor, F-Block, Vikaspuri
West Delhi; Delhi; Postal Code: 110018

Contact Details: Purchase the Acton Pharma Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Acton Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Acton Pharma Private Limited report to view the information.
Incorporation Date:
May 15, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Acton Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
22.64%
Total operating revenue
19.99%
Operating profit (EBIT)
23.05%
EBITDA
23.51%
Net Profit (Loss) for the Period
12.78%
Total assets
15.27%
Total equity
38.26%
Operating Profit Margin (ROS)
0.08%
Net Profit Margin
-1.45%
Return on Equity (ROE)
-6.26%
Quick Ratio
1.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?